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Oxidative stress is one of the pathologicalmechanisms responsible for the beta- amyloid cascade associatedwithAlzheimer’s disease
(AD). Previous studies have demonstrated the role of carnosic acid (CA), an effective antioxidant, in combating oxidative stress.
A progressive cognitive decline is one of the hallmarks of AD.Thus, we attempted to determine whether the administration of CA
protects against memory deficit caused by beta-amyloid toxicity in rats. Beta-amyloid (1–40) was injected by stereotaxic surgery
into the Ca1 region of the hippocampus of rats in the Amyloid beta (A𝛽) groups. CA was delivered intraperitoneally, before and
after surgery in animals in the CA groups. Passive avoidance learning and spontaneous alternation behavior were evaluated using
the shuttle box and the Y-maze, respectively. The degenerating hippocampal neurons were detected by fluoro-jade b staining. We
observed that beta-amyloid (1–40) can induce neurodegeneration in the Ca1 region of the hippocampus by using fluoro-jade b
staining. Also, the behavioral tests revealed that CA may recover the passive avoidance learning and spontaneous alternation
behavior scores in the A𝛽 + CA group, in comparison with the A𝛽 group. We found that CA may ameliorate the spatial and
learning memory deficits induced by the toxicity of beta-amyloid in the rat hippocampus.
1. Introduction
Thedepositions of amyloid𝛽 protein (A𝛽) in the extracellular
neuritic plaques, neurofibrillary tangles containing hyper-
phosphorylated tau protein in the neurons of the hippocam-
pus and other parts of the cortex resulting in brain atrophy,
are themost important neuropathological features associated
with Alzheimer’s disease (AD) [1–3]. An insidious onset
of memory deterioration, progressive cognitive impairment,
and behavioral disturbances are known to be important
symptoms in AD [4]. The A𝛽 cascade hypothesis, which was
developed in the early 1980s, shows that in the first phase
of this disease, the deposition of amyloid plaques may affect
cognition [5]. Increased permeability of the cell membranes,
apoptosis, inflammatory reactions, and free radical damage
are among the mechanisms that underlie A𝛽 neurotoxicity
[6]. It has recently been accepted that oxidative stress also
plays an important role in the pathogenesis of Alzheimer’s
disease [7].
Antioxidants can protect against the oxidative stress
damage in different ways, including the inhibition of reactive
oxygen species (ROS) formation [8].
Carnosic acid (CA), an important polyphenolic antioxi-
dant, has been identified in Rosmarinus officinalis (rosemary
plant) [9]. It is a lipophilic antioxidant with the ability to
prevent lipid peroxidation and biological membrane disrup-
tion by scavenging oxygen hydroxyl radicals and lipid peroxyl
radicals [10].
Additionally, it has been shown that CA could induce
the transcriptional activation of antioxidant phase 2 enzymes
such as electrophilic compounds.Thus, this type of neuropro-
tection could have beneficial effects in chronic neurodegener-
ative diseases like Parkinson’s andAlzheimer’s [11]. Our group
has previously reported that CA protects the hippocampal
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neurons and decreases cellular death in an animal model of
Alzheimer’s disease [12].
Therefore, the present study aims to evaluate the protec-
tive effects of carnosic acid on cognitive impairment against
the neurotoxicity induced by A𝛽 in the rat hippocampus.
2. Materials and Methods
2.1. Materials. A𝛽-protein fragment (1–40) and carnosic acid
were purchased from Sigma Chemical Co. (Saint Louis,
MO, USA) and A.G. Scientific Co. (San Diego, CA, USA),
respectively. Fluoro-jade b was purchased from Millipore
(Billerica, MA, USA). A𝛽 (1–40) was dissolved in deionized
water to a final concentration of 1.5 nmol/𝜇L and stored at
−70∘C before use. CA was dissolved in DMSO and stored at
−20∘C before use. Immediately prior to injection, PBS was
added to CA + DMSO (PBS/DMSO: 10/1).
2.2. Animals. The male Wistar rats (Pasteur’s Institute,
Tehran, Iran) (𝑛 = 42) weighing 240–280 g that were used
in this study were housed in the animal lab of the Iran
University ofMedical Sciences.The animals were maintained
in laboratory cages (3 animals/cage) under a 12 h light/dark
cycle, at a room temperature of 21 ± 2∘C, and they had free
access to food and water.
All the animal procedures were approved by the Animal
Care Committee of the Chancellor for Research of the Iran
University ofMedical Sciences (Tehran, Iran), and all possible
steps were taken to stay away from animals’ suffering at each
stage of experiments.
The animals were divided into six groups: control, vehicle,
sham surgery, carnosic acid (CA), Amyloid beta (A𝛽), and
carnosic acid + A𝛽 (A𝛽 + CA). Animals in the A𝛽 groups
were administered 1.5 nm/𝜇L beta-amyloid (1–40) in the Ca1
region on both sides of the hippocampus. Animals in the
CA groups received 1 mL of CA solution (CA: 10mg/kg)
intraperitoneally, 1 hour prior to surgery.This treatment (CA:
3mg/kg) continued a couple of hours after surgery and,
subsequently, each afternoon for up to 12 days.
2.3. Methods
2.3.1. Surgical Procedure. Animals were first anesthetized by
the intraperitoneal (IP) injection of ketamine (100mg/kg)
and xylazine (20mg/kg) and then positioned on a stereo-
taxic apparatus (Stoelting Co., USA). The injections were
delivered through a 5𝜇L Hamilton syringe at the level of
the hippocampus, as following coordinates: antero-posterior,
−3.8mm; lateral,±2.6mm frombregma and−2.8mmventral
from the dura. Each injection lasted for 5 minutes, and the
needle was kept in place for an additional 5 minutes before
being slowly withdrawn.
12 days after surgery, behavioral tests were performed on
the animals in the animal lab of the IranUniversity ofMedical
Sciences.
2.3.2. Passive Avoidance Task. The passive avoidance task
was performed using the shuttle box to study the learning
memory status in rats.The shuttle box consists of two equally
sized compartments, with a guillotine (execution) door and
a grid floor for the delivery of an electric foot shock. An
electric light bulb illuminates one compartment, while the
other remains in the dark. During the training session, the
animals were individually placed in the light chamber, facing
away from the execution door. When the animal entered the
darkened compartment, the door was quietly lowered and
a 0.5mA foot shock was applied for 2 seconds through the
grid floor. During the test session, the animal was placed
in the light compartment once more, to enter the dark
compartment, but the foot shock was not applied.The latency
to step through was recorded [13]. Time latency was recorded
up to a maximum of 300 seconds.
2.3.3. Y-Maze Spatial Memory. Spontaneous alternation
behavior was performed using the Y- maze apparatus to
study short-term spatial memory in rats. The Y-maze appa-
ratus, made of gray Plexiglas and covered with a black
paper, is shaped like a Y, with three identical arms with an
angle of 120∘ between each pair of arms [14]. Each arm is
40 cm long, 30 cm high, and 15 cm wide. The arms come
together in a central area to form an equilateral triangle
that is 15 cm at its longest axis. Each animal was set out
at the end of one arm and was then allowed to move
freely inside the maze in an 8-minute session. When the
base of the animal’s tail was completely placed in the arm,
each arm entrance was recorded visually (e.g., ABC, BBC,
CBA, ABB, C). An alternation was defined as successive
entries into the different three arms on overlapping triplet
sets (i.e., ABC, CBA) [15]. The percentage of spontaneous
alternation behavior was calculated as the ratio of actual to
potential alternations as follows: PercentAlternation=Actual
Alternation (i.e., ABC, CBA: 6)/[Maximum Alternation (i.e.,
ABCBBCCBAABBC: 13) − 2] × 100 = (6/11) × 100 = 54.54%
[16].
2.3.4. Fluoro-Jade b Staining. Fourteen days following
surgery, when the behavioral tests were conducted, rats
were perfused with 4% paraformaldehyde in 0.1M phosphate
buffer (pH 7.4), and then the brains were extracted and placed
in the same solution. The paraffin slides were mounted on
gelatin-coated slides and stained with fluoro-jade b, a
fluorescent staining technique for the detection of neuronal
degeneration. The staining protocol was conducted as
described by Schmued, LC (2000). Briefly, the sections of
the brain were immersed in xylene and then placed in a
solution containing 1% sodium hydroxide in 80% alcohol,
followed by 2min in 70% alcohol and 2min in distilled water,
and then the slides were transferred to a solution of 0.06%
potassium permanganate for 10min. Following rinsing in
distilled water, the slides were placed in the fluoro-jade
b staining solution (0.0004%) for about 20min. Finally,
the dry slides were cleared by immersion in xylene and
mounted in water-free mounting medium, DPX, and a cover
slip was placed on top. The sections were inspected with a
40x objective, using the FITC filter for the observation of
neuronal degeneration [17].
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Data were expressed as mean ± standard error of the
mean (S.E.M.) and analyzed by the SPSS statistical software
package (version 17). One-way ANOVA was used to analyze
the difference between groups. Post hoc between-group
comparisons were done using least square difference (LSD).
3. Results
Because there were no significant differences in the results
between control, vehicle, and sham surgery groups, the
results of these three groups are pooled together and shown
as control group only.
3.1. Behavioral Results. A significant decrease in the passive
avoidance learning and spatial Y-maze alternation scores was
observed in the A𝛽 group, in comparison with the A𝛽 + CA
group.
3.1.1. Passive Avoidance Task. As shown in Figure 1, there is
a significant decrease in the step-through latency in the A𝛽
group as compared to the control and the CA group (𝑃 <
0.01). Additionally, there is a significant increase in the step-
through latency in the A𝛽 + CA group as compared to the
A𝛽 group (𝑃 < 0.05). The mean step-through latency for the
control, CA, A𝛽, and A𝛽 + CA groups was 202.1 ± 48.5, 187.4
± 44.3, 18 ± 4.9, and 184.8 ± 50.5, respectively.
3.1.2. Spatial Y-Maze Memory. As shown in Figure 2, the
mean percent alternation behavior for the control, CA, A𝛽,
and A𝛽 + CA groups was 93.6 ± 5.3, 86 ± 14.3, 54.3 ± 6.1,
and 89 ± 9.7, respectively. Thus, a significant decrease in the
percent alternation behavior was observed in the A𝛽 group
as compared to the control group (𝑃 < 0.05). Additionally,
a significant increase in the percent alternation behavior was
observed in the A𝛽 + CA group in comparison with the A𝛽
group (𝑃 < 0.05).
3.2. Fluoro-Jade b Staining. Fluoro-jade b is recently used
as a fluorescent marker for neuronal cell death and binds
sensitively and specifically to the degenerating neurons. The
positive neurons were observed with the green iridescence.
Figure 3 presents the fluoro-jade b staining in the Ca1 region
of the hippocampus for the control, CA, A𝛽, and A𝛽 +
CA groups. As it is shown, there are so many degenerating
neurons in the A𝛽 group, while there are fewer in A𝛽 + CA
group, and there are not any positive neurons observed in
control and CA groups.
4. Discussion
In Alzheimer’s disease, lack of memory is one of the first
symptoms to occur [18].Therefore, in this study, we proposed
a strategy against the in vivo A𝛽 (1–40) toxicity. The spatial
and learning memories in rats were investigated using the
Y-maze and shuttle box apparatus to compare their score
changes in accordance with the protective role allocated to
CA against A𝛽 toxicity.
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Figure 1: Step-through latency in the experimental groups (control,
CA: carnosic acid, A𝛽: Amyloid beta, and A𝛽 + CA: carnosic acid +
A𝛽) (mean ± SEM): ∗∗𝑃 < 0.01 compared to the control; #𝑃 < 0.05
compared to the CA group; +𝑃 < 0.05 compared to the A𝛽 group.
100
120
80
60
40
20
0
Control
A
lte
rn
at
iv
e b
eh
av
io
r
CA A𝛽 A𝛽 + CA
∗
#
Figure 2: The percent of alternation behavior in the experimental
groups (control, CA: carnosic acid, A𝛽: Amyloid beta, andA𝛽 +CA:
carnosic acid + A𝛽) (mean ± SEM): ∗𝑃 < 0.05 compared to the
control group and #𝑃 < 0.05 compared to the A𝛽 group.
Yan et al. showed that the injection of A𝛽 (1–42) impairs
performance on the passive avoidance test (35% decreases
in step-through latency) and the Y-maze test (19% decreases
in alternation behavior) [19]. In another study, Rasoolijazi et
al. found that the unilateral intrahippocampal injection of
4 𝜇L of 2 nmol/𝜇L A𝛽 (1–40) can reduce spatial memory and
psychomotor coordination (PMC) in rats [20]. Additionally,
work from our own laboratory recently showed that a
bilateral intrahippocampal injection of 4 𝜇L of 1.5 nmol/𝜇L
A𝛽 (1–40) can induce neuronal loss in the Ca1 region of the
hippocampus [12].
Based on the results of the present study, we showed
that the neuronal loss in the Ca1 region of the hippocampus
induced by A𝛽 (1–40) may result in part from neuronal
degeneration, as demonstrated by fluoro-jade b staining.
Studies showed that consequent to neural lesions, the
decreased latency to step-through is caused by several kinds
of cognitive deficits [21]. In this study, we showed that A𝛽
(1–40) can induce the impairment of scores in alternation
behavior and passive avoidance tasks in rats.
Researchers observed that CA activates the Keap1/Nrf2
transcriptional factor, thereby protecting neurons from
oxidative stress and excitotoxicity. In cerebrocortical cul-
tures, CA-biotin accumulates in nonneuronal cells at low
concentrations and in neurons at higher concentrations.
Furthermore, based on the fact that CA can transfer into the
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Figure 3: Fluoro-jade b staining in the Ca1 area of the hippocampus in the experimental groups (control, CA: carnosic acid, A𝛽: Amyloid
beta, and A𝛽 +CA: carnosic acid +A𝛽).Thewhite arrows show the fluorescent positive neurons in the Ca1 region of the hippocampus (400x).
brain, a single intraperitoneal injection of CA (1mg/kg) 1 h
prior to MCAO (middle cerebral artery occlusion) protects
the brain against the toxic effects of the ischemia/reperfusion
[11].
In addition to the antioxidant activity of carnosic acid
[22], it has been reported to have several other beneficial
effects, including chemoprotective effects in the presence
of carcinogens, suppression of metalloproteinase-1 mRNA
expression which is induced by UVA irradiation[23], anti-
inflammatory effect [24], and neurotrophic activities [25].
Furthermore, Ninomiya et al. (2004) showed that oral
administration of CA at a dose of 20mg/kg/day for 14 days
suppressed the increased epididymal fat and bodyweight gain
in high fat diet-fed mice [26]. Additionally, CA can protect
photoreceptors against light-induced oxidative damage and
retinal dysfunction [27].
In this study, due to the passive shock avoidance learning
test results, there is a 90.3% increase in the mean score of the
A𝛽 + CA group as compared to the A𝛽 group. The results
of the short-term spatial memory test demonstrated a 39%
increase in themean score in theA𝛽+CAgroup as compared
to the A𝛽 group.
5. Conclusion
Taken together, it is suggested that the administration of CA
could significantly improve short-term spatial and learning
memory scores following their impairment by A𝛽 toxicity.
This protective role may be due to the antioxidant, anti-
inflammatory, and neurotrophic activities of CA. Therefore,
CA may be considered as a chemopreventive agent against
neurodegenerative disorders like Alzheimer’s disease.
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